High-performance liquid chromatographic-tandem mass spectrometric method for the determination of ethionamide in human plasma, bronchoalveolar lavage fluid and alveolar cells

被引:23
作者
Conte, JE
Wang, GF
Lin, ET
Zurlinden, E
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, Infect Dis Res Lab, San Francisco, CA 94117 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94117 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94117 USA
[4] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94117 USA
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 753卷 / 02期
关键词
ethionamide;
D O I
10.1016/S0378-4347(00)00572-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed and validated an accurate, sensitive, and rapid high-performance liquid chromatographic-tandem mass spectrometric method (HPLC-MS-MS) for the determination of ethionamide in plasma, bronchoalveolar fluid (BAL) and alveolar cells (AC). The retention times for ethionamide, clemastine fumarate (internal standard for plasma), promethazine (internal standard for plasma) and propranolol (internal standard for BAL and AC) were approximately 2.62, 1.21, 2.14, and 2.22 min, respectively, with a total run time of 3.2 min. Ethionamide detection for plasma was carried out on a PE Sciex API III (Perkin-Elmer, Foster City, CA, USA). BAL and cell pellets and some plasma specimens were analyzed on a Micromass Quattro LC (Micromass Co., Manchester, UK), The detection limits for ethionamide were 0.05 mug/ml for plasma, and 0.005 mug/ml for BAL supernatants and alveolar cell suspensions. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:343 / 353
页数:11
相关论文
共 17 条
  • [1] Abate G, 1998, INT J TUBERC LUNG D, V2, P580
  • [2] Intrapulmonary concentrations of pyrazinamide
    Conte, JE
    Golden, JA
    Duncan, S
    McKenna, E
    Zurlinden, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1329 - 1333
  • [3] Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects
    Conte, JE
    Golden, J
    Duncan, S
    McKenna, E
    Lin, E
    Zurlinden, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1617 - 1622
  • [4] INTRAPULMONARY PHARMACOKINETICS OF CLARITHROMYCIN AND OF ERYTHROMYCIN
    CONTE, JE
    GOLDEN, JA
    DUNCAN, S
    MCKENNA, E
    ZURLINDEN, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 334 - 338
  • [5] GRONROOS JA, 1964, CURR THER RES CLIN E, V6, P105
  • [6] Heifets L B., 1991, DRUG SUSCEPTIBILITY, P89
  • [7] COMPARISON OF BACTERIOSTATIC AND BACTERICIDAL ACTIVITY OF ISONIAZID AND ETHIONAMIDE AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS
    HEIFETS, LB
    LINDHOLMLEVY, PJ
    FLORY, M
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (02): : 268 - 270
  • [8] A COMPARISON OF THE BLOOD-LEVELS AND URINARY-EXCRETION OF ETHIONAMIDE AND PROTHIONAMIDE IN MAN
    JENNER, PJ
    ELLARD, GA
    GRUER, PJK
    ABER, VR
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (03) : 267 - 277
  • [9] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ETHIONAMIDE AND PROTHIONAMIDE IN BODY-FLUIDS
    JENNER, PJ
    ELLARD, GA
    [J]. JOURNAL OF CHROMATOGRAPHY, 1981, 225 (01): : 245 - 251
  • [10] PELOQUIN CA, 1991, PHARMACOTHERAPY, V11, P359